BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

LD-2 disclosure · 3rd Quarter - Amendment

WATSON PHARMACEUTICALS INC

via RUBICON ADVISORS, LLC

3rd Quarter (July 1 - Sep 30) · 2008Posted Oct 31, 2008Filing document ↗LDA record ↗

Income$102Kfee reported

Client

Name: WATSON PHARMACEUTICALS INC
Location: District of Columbia · United States of America

Registrant

Firm: RUBICON ADVISORS, LLC
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Healthcare: Pharmaceuticals, Prescription Drug User Fee
LobbyistsKATHY KULKARNI · WILLIAM BURKE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

WATSON PHARMACEUTICALS INC — Lobbying — Receipts Report